Conley Chee
Chief Executive Officer en SYROS PHARMACEUTICALS, INC. .
Fortuna: 120 396 $ al 31/03/2024
Perfil
Conley Chee is currently the President & Chief Executive Officer at Syros Pharmaceuticals, Inc. He previously worked at Novartis Pharmaceuticals as the Global Head-Portfolio Management.
Mr. Chee completed his undergraduate degree at the University of Alberta and holds an MBA from the Richard Ivey School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/04/2024 | 22 504 ( 0.09% ) | 120 396 $ | 31/03/2024 |
Cargos activos de Conley Chee
| Empresas | Cargo | Inicio |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Chief Executive Officer | 02/12/2023 |
Antiguos cargos conocidos de Conley Chee.
| Empresas | Cargo | Fin |
|---|---|---|
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The private company is based in Basel, Germany. | Corporate Officer/Principal | - |
Formación de Conley Chee.
| University of Alberta | Undergraduate Degree |
| Richard Ivey School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The private company is based in Basel, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Conley Chee
